Navigation
banner

Diabetes Summit

2018-02-242018-02-272018-01-19
EARLY BIRD DISCOUNT! Register by Feb 27, 2018 to receive 10% off your registration!
Or Register 3 for the price of 2 with the coupon code rcdvb!


registration button

registration button

Subscribe for updates




Dear Colleague,

GTCbio and the advisory board would like to invite you to the 11th Diabetes Summit to be held April 9-11, 2018 in Boston, MA. GTCbio’s Diabetes Summit encompasses the drug discovery and partnering aspects of diabetes. Experts from industry and academia will discuss strategies to target Type 1 and Type 2 diabetes in presentations, panels and round-table discussions, highlight basic research, novel therapeutic targets, translation to the clinic, devices and digital aids, funding and partnering trends, emerging technologies and other relevant topics.

Focus Groups Discussions:

  1. Part I (Challenges and Opportunities)
  2. Part II (Solutions & Action Items)

Drug Discovery & Development for Diabetes:

  1. Opening Keynote Session – Historical Perspective & State of the Science & Industry 
  2. Type I Diabetes – Preclinical & Clinical Development
  3. Type II Diabetes – Preclinical & Clinical Development
  4. Devices & Digital Aids in Diabetes Management

Funding, Partnering & Commercialization of Diabetes Technologies:

  1. Industry Partnering with Academia & CROs to Advance Diabetes Research
  2. Funding & Commercialization of Diabetes Technologies
  3. Award Ceremony & Closing Keynote Session – Predictions for the Future
  4. Keynote Panel Discussion

 

We look forward to seeing you at the conference!

Best regards,

The 2018 Advisory Committee

2018 Advisory Board Members
Robert Geho, Diasome Pharmaceuticals Inc
Zan Fleming, Kinexum
Alan Cherrington, Vanderbilt
Brian T. Bloomquist, Eli Lilly
Aaron Schwartz, Novo Nordisk
Riccardo Perfetti, Sanofi Diabetes & Cardiovascular Business Unit
Nandan Padukone, Joslin Diabetes Center
Thomas Seoh, Kinexum
Jonathan Behr, JDRF
Nathaniel Heintzman, Dexcom
Vivek Shenoy, Renovo Neural
Judith Gorski, Crown Bioscience
Vijay Koya, Boston Scientific